|
ZNF124 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.746600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.622200E-01 |
| Normal-vs-Stage2 |
7.344600E-01 |
| Normal-vs-Stage3 |
8.270400E-01 |
| Normal-vs-Stage4 |
3.757800E-01 |
| Stage1-vs-Stage2 |
5.912000E-01 |
| Stage1-vs-Stage3 |
9.626000E-01 |
| Stage1-vs-Stage4 |
6.008200E-01 |
| Stage2-vs-Stage3 |
6.634400E-01 |
| Stage2-vs-Stage4 |
3.742000E-01 |
| Stage3-vs-Stage4 |
5.835400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.909800E-01 |
| Normal-vs-AfricanAmerican |
4.660200E-01 |
| Normal-vs-Asian |
5.198200E-01 |
| Caucasian-vs-AfricanAmerican |
3.271800E-01 |
| Caucasian-vs-Asian |
6.918400E-01 |
| AfricanAmerican-vs-Asian |
8.984200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.953000E-01 |
| Normal-vs-Female |
3.044200E-01 |
| Male-vs-Female |
1.504400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.165200E-01 |
| Normal-vs-Extreme_Weight |
2.632800E-01 |
| Normal-vs-Obese |
9.626800E-01 |
| Normal-vs-Extreme_Obese |
8.526600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.669600E-01 |
| Normal_Weight-vs-Obese |
8.967000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.215600E-01 |
| Extreme_Weight-vs-Obese |
3.284600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.477800E-01 |
| Obese-vs-Extreme_Obese |
8.538000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.834400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.417400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.384200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.618100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.289200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.685200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.617700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.132300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.704200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.149000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.726000E-01 |
| Normal-VS-Type2 PRCC |
1.950250E-01 |
| Normal-VS-KIRP CIMP |
1.420190E-02 |
| Normal-VS-Unclassified PRCC |
8.243000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.790400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.876200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.708800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.970200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.728600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.754040E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.683400E-01 |
| Normal-vs-N1 |
6.187800E-01 |
| Normal-vs-N2 |
5.213500E-04 |
| N0-vs-N1 |
2.859600E-01 |
| N0-vs-N2 |
2.706300E-02 |
| N1-vs-N2 |
6.508300E-02 |
|
|
